Diagnosis, treatment, and new developments in preeclampsia

Katherine W. Arendt, William Hartman, Vesna D. Garovic

Research output: Contribution to journalReview articlepeer-review


Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5% of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.

Original languageEnglish (US)
Pages (from-to)297-302
Number of pages6
JournalCurrent Women's Health Reviews
Issue number4
StatePublished - Nov 2010


  • Eclampsia
  • Preeclampsia
  • Pregnancy induced hypertension

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Diagnosis, treatment, and new developments in preeclampsia'. Together they form a unique fingerprint.

Cite this